Back

Integrated care improves outcomes in multimorbid patients with atrial fibrillation: insights from the MIRACLE-AF trial

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ming Fang Li

The First Affiliated Hospital of Nanjing Medical University, Nanjing (China)

6 More presentations in this session

Presentation thumbnail
Association between biological aging acceleration and adverse cardiovascular prognosis in atrial fibrillation patients: a multicenter real-world cohort study
Professor T. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Renal function and outcomes in subclinical atrial fibrillation: a prespecified analysis of the ARTESIA trial
Doctor R. Reddy (Durham, US)
Abstract Slides Video
Presentation thumbnail
Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Primary care physician continuity improve survival in patients with atrial fibrillation: a retrospective analysis of 15,000 patients with atrial fibrillation
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis
Miss L. Serio (L'Aquila, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China
1 September 2024
thumbnail
Congress Presentation
Multimorbidity, polypharmacy, and frailty: the healthcare and economic burden seen in the atrial fibrillation population
30 August 2026
thumbnail
Congress Presentation
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention: a systematic review and individual patient data network meta-analysis.
30 August 2026
thumbnail
Congress Presentation
Mobile health technology integrated care in atrial fibrillation patients according to polypharmacy: an analysis of the mAFA-II clinical trial
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources